Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Status and Outlook 2018-2025

August 2018 | 145 pages | ID: GB68CAED6D0EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Merck & Co., Inc.
• GlaxoSmithKline plc
• Tesaro, Inc.
• Helsinn Group
• F. Hoffmann-La Roche Ltd.
• Heron Therapeutics, Inc.
• Dr. Reddy's Laboratories Ltd.
• Acacia Pharma
• Sun Pharmaceutical Industry Ltd.
• Otsuka Holdings Co., Ltd.

Market by Type

• Existing Drugs
• Akynzeo (Netupitant-Palonosetron FDC)
• Aloxi (Palonosetron)
• Emend (Aprepitant)
• Kytril Generic (Granisetron)
• Zofran Generic (Ondansetron)
• Pipeline Drugs
• SUSTOL (Granisetron Injection extended release)
• Rolapitant

Market by Application

• Serotonin Receptor Antagonists
• NK1 Receptor Antagonists

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Existing Drugs
  3.1.2 Akynzeo (Netupitant-Palonosetron FDC)
  3.1.3 Aloxi (Palonosetron)
  3.1.4 Emend (Aprepitant)
  3.1.5 Kytril Generic (Granisetron)
  3.1.6 Zofran Generic (Ondansetron)
  3.1.7 Pipeline Drugs
  3.1.8 SUSTOL (Granisetron Injection extended release)
  3.1.9 Rolapitant
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Serotonin Receptor Antagonists
  4.1.2 NK1 Receptor Antagonists
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Existing Drugs Production by Region
    6.1.1.2 Akynzeo (Netupitant-Palonosetron FDC) Production by Region
    6.1.1.3 Aloxi (Palonosetron) Production by Region
    6.1.1.4 Emend (Aprepitant) Production by Region
    6.1.1.5 Kytril Generic (Granisetron) Production by Region
    6.1.1.6 Zofran Generic (Ondansetron) Production by Region
    6.1.1.7 Pipeline Drugs Production by Region
    6.1.1.8 SUSTOL (Granisetron Injection extended release) Production by Region
    6.1.1.9 Rolapitant Production by Region
  6.1.2 Production by Application
    6.1.2.1 Serotonin Receptor Antagonists Production by Region
    6.1.2.2 NK1 Receptor Antagonists Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Existing Drugs Demand by Region
    6.2.1.2 Akynzeo (Netupitant-Palonosetron FDC) Demand by Region
    6.2.1.3 Aloxi (Palonosetron) Demand by Region
    6.2.1.4 Emend (Aprepitant) Demand by Region
    6.2.1.5 Kytril Generic (Granisetron) Demand by Region
    6.2.1.6 Zofran Generic (Ondansetron) Demand by Region
    6.2.1.7 Pipeline Drugs Demand by Region
    6.2.1.8 SUSTOL (Granisetron Injection extended release) Demand by Region
    6.2.1.9 Rolapitant Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Serotonin Receptor Antagonists Demand by Region
    6.2.2.2 NK1 Receptor Antagonists Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Merck & Co., Inc.
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 GlaxoSmithKline plc
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Tesaro, Inc.
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Helsinn Group
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 F. Hoffmann-La Roche Ltd.
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Heron Therapeutics, Inc.
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Dr. Reddy's Laboratories Ltd.
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Acacia Pharma
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Sun Pharmaceutical Industry Ltd.
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Otsuka Holdings Co., Ltd.
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Chemotherapy-Induced Nausea and Vomiting Drugs Industry Dynamics & Regulations List
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue, Cost and Margin, 2015-2018E
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Status by Type 2015-2018E, in USD Million
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Status by Application 2015-2018E, in USD Million
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Status by Application 2015-2018E, in Volume
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Region 2015-2018E, in USD Million
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Region in 2018, in USD Million
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market by Region 2015-2018E, in Volume
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Region in 2018, in Volume
Table Existing Drugs Production Value by Region 2015-2018E, in USD Million
Table Existing Drugs Production Volume by Region 2015-2018E, in Volume
Table Akynzeo (Netupitant-Palonosetron FDC) Production Value by Region 2015-2018E, in USD Million
Table Akynzeo (Netupitant-Palonosetron FDC) Production Volume by Region 2015-2018E, in Volume
Table Aloxi (Palonosetron) Production Value by Region 2015-2018E, in USD Million
Table Aloxi (Palonosetron) Production Volume by Region 2015-2018E, in Volume
Table Emend (Aprepitant) Production Value by Region 2015-2018E, in USD Million
Table Emend (Aprepitant) Production Volume by Region 2015-2018E, in Volume
Table Kytril Generic (Granisetron) Production Value by Region 2015-2018E, in USD Million
Table Kytril Generic (Granisetron) Production Volume by Region 2015-2018E, in Volume
Table Zofran Generic (Ondansetron) Production Value by Region 2015-2018E, in USD Million
Table Zofran Generic (Ondansetron) Production Volume by Region 2015-2018E, in Volume
Table Pipeline Drugs Production Value by Region 2015-2018E, in USD Million
Table Pipeline Drugs Production Volume by Region 2015-2018E, in Volume
Table SUSTOL (Granisetron Injection extended release) Production Value by Region 2015-2018E, in USD Million
Table SUSTOL (Granisetron Injection extended release) Production Volume by Region 2015-2018E, in Volume
Table Rolapitant Production Value by Region 2015-2018E, in USD Million
Table Rolapitant Production Volume by Region 2015-2018E, in Volume
Table Serotonin Receptor Antagonists Production Value by Region 2015-2018E, in USD Million
Table Serotonin Receptor Antagonists Production Volume by Region 2015-2018E, in Volume
Table NK1 Receptor Antagonists Production Value by Region 2015-2018E, in USD Million
Table NK1 Receptor Antagonists Production Volume by Region 2015-2018E, in Volume
Table Existing Drugs Market Size by Region 2015-2018E, in USD Million
Table Existing Drugs Market Size by Region 2015-2018E, in Volume
Table Akynzeo (Netupitant-Palonosetron FDC) Market Size by Region 2015-2018E, in USD Million
Table Akynzeo (Netupitant-Palonosetron FDC) Market Size by Region 2015-2018E, in Volume
Table Aloxi (Palonosetron) Market Size by Region 2015-2018E, in USD Million
Table Aloxi (Palonosetron) Market Size by Region 2015-2018E, in Volume
Table Emend (Aprepitant) Market Size by Region 2015-2018E, in USD Million
Table Emend (Aprepitant) Market Size by Region 2015-2018E, in Volume
Table Kytril Generic (Granisetron) Market Size by Region 2015-2018E, in USD Million
Table Kytril Generic (Granisetron) Market Size by Region 2015-2018E, in Volume
Table Zofran Generic (Ondansetron) Market Size by Region 2015-2018E, in USD Million
Table Zofran Generic (Ondansetron) Market Size by Region 2015-2018E, in Volume
Table Pipeline Drugs Market Size by Region 2015-2018E, in USD Million
Table Pipeline Drugs Market Size by Region 2015-2018E, in Volume
Table SUSTOL (Granisetron Injection extended release) Market Size by Region 2015-2018E, in USD Million
Table SUSTOL (Granisetron Injection extended release) Market Size by Region 2015-2018E, in Volume
Table Rolapitant Market Size by Region 2015-2018E, in USD Million
Table Rolapitant Market Size by Region 2015-2018E, in Volume
Table Serotonin Receptor Antagonists Market Size by Region 2015-2018E, in USD Million
Table Serotonin Receptor Antagonists Market Size by Region 2015-2018E, in Volume
Table NK1 Receptor Antagonists Market Size by Region 2015-2018E, in USD Million
Table NK1 Receptor Antagonists Market Size by Region 2015-2018E, in Volume
Table GlobalChemotherapy-Induced Nausea and Vomiting Drugs Forecast by Type 2019F-2025F, in USD Million
Table Chemotherapy-Induced Nausea and Vomiting Drugs Forecast by Type 2019F-2025F, in Volume
Table Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast by Region 2019F-2025F, in USD Million
Table Chemotherapy-Induced Nausea and Vomiting Drugs Market Forecast by Region 2019F-2025F, in Volume
Table Merck & Co., Inc. Information
Table Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Cost, Margin of Merck & Co., Inc.
Table GlaxoSmithKline plc Information
Table Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Cost, Margin of GlaxoSmithKline plc
Table Tesaro, Inc. Information
Table Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Cost, Margin of Tesaro, Inc.
Table Helsinn Group Information
Table Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Cost, Margin of Helsinn Group
Table F. Hoffmann-La Roche Ltd. Information
Table Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Cost, Margin of F. Hoffmann-La Roche Ltd.
Table Heron Therapeutics, Inc. Information
Table Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Cost, Margin of Heron Therapeutics, Inc.
Table Dr. Reddy's Laboratories Ltd. Information
Table Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Cost, Margin of Dr. Reddy's Laboratories Ltd.
Table Acacia Pharma Information
Table Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Cost, Margin of Acacia Pharma
Table Sun Pharmaceutical Industry Ltd. Information
Table Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Cost, Margin of Sun Pharmaceutical Industry Ltd.
Table Otsuka Holdings Co., Ltd. Information
Table Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Cost, Margin of Otsuka Holdings Co., Ltd.
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue by Company 2015-2017, in USD Million
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume by Company 2015-2017, in Volume
Table Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Chemotherapy-Induced Nausea and Vomiting Drugs Picture
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Industry Chain Diagram
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue 2015-2018E, in USD Million
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume 2015-2018E, in Volume
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Status by Type 2015-2018E, in Volume
Figure North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2015-2018E, in USD Million
Figure North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2015-2018E, in Volume
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2015-2018E, in Volume
Figure South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2015-2018E, in USD Million
Figure South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2015-2018E, in Volume
Figure Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2015-2018E, in Volume
Figure Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size and Growth 2015-2018E, in Volume
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Price Forecast 2019F-2025F
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Gross Margin Forecast 2019F-2025F
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Revenue by Company in 2018, in USD Million
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Company in 2018
Figure Global Chemotherapy-Induced Nausea and Vomiting Drugs Gross Margin by Company in 2018